Heart attack survivorship tied to long-term health consequences
Mar 04, 2024
An increased risk was seen for atrial fibrillation and cerebrovascular disease, among others.
Position statement addresses optimal management of diabetes
Feb 21, 2024
Tools available to help healthcare providers include guided communication styles and clinical screening tools for psychosocial conditions.
Exercise intensity, duration can affect CKD risk in obesity, type 2 diabetes
Feb 07, 2024
An inverse link was seen for total moderate-to-vigorous physical activity and MVPA accumulated in bouts of ≥10 minutes with progression to chronic kidney disease in overweight/obese adults with type...
Type 2 diabetes remission likely with weight loss after diagnosis
Jan 23, 2024
An increased likelihood of diabetes remission and a reduced risk for returning to hyperglycemia were seen with weight loss in a year after diagnosis.
FDA finds no evidence linking Wegovy, Ozempic to suicidal behaviors
Jan 12, 2024
The agency, however, noted that officials cannot rule out that “a small risk may exist,” and said it will continue to investigate.
Dapagliflozin cuts cardiovascular events in patients with heart failure, T2D
Dec 27, 2023
Dapagliflozin, however, does not reduce the urinary albumin-to-creatinine ratio in those patients.
New poll finds older Americans believe Medicare should cover weight-loss drugs
Dec 13, 2023
A 2003 law currently prohibits Medicare from covering medications specifically for weight loss. The poll was among those aged 50 to 80.
Statin use increased from 1999-2000 to 2013-2014, then plateaued
Dec 04, 2023
No change was seen in the proportion using statins from 2013-2014 to 2017-2018 for those with diabetes and with ASCVD risk greater than 20%.
Lipid-lowering drugs save lives, but use decreasing
Dec 01, 2023
In 2019 to 2020, 56% of patients with high cholesterol were on statins for primary prevention and 85% were on them for secondary prevention.
Walking at faster speeds linked to reduction in risk for type 2 diabetes
Nov 29, 2023
The risk for type 2 diabetes was significantly reduced at a walking speed of 4 km/hour and greater based on dose-response analysis.